Chemokine receptor antagonists and methods of use thereof
US8653096B2 · kind B2 · utility
1Cited by
52References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 26, 2011 |
| Grant date | Feb 18, 2014 |
| Priority date | — |
| Expiry date | Sep 26, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Disclosed are novel compounds and a method of treating a disease associated with aberrant leukocyte recruitment and/or activation. The method comprises administering to a subject in need an effective amount of a compound represented by:or physiologically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.